Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Stock
Stocks
600329
CNE000001808
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38.29 CNY | -0.03% |
|
+4.59% | -16.07% |
| Market Cap | 25.6B 3.79B 3.29B 3.07B 2.82B 5.32B 362B 5.4B 36.14B 14.19B 180B 14.23B 13.92B 604B | P/E 2024 |
10.7x | P/E 2025 | 16.5x |
|---|---|---|---|---|---|
| Enterprise Value | 21.34B 3.16B 2.75B 2.56B 2.35B 4.43B 302B 4.5B 30.13B 11.83B 150B 11.87B 11.6B 503B | EV / Sales 2024 |
2.3x | EV / Sales 2025 | 5.39x |
| Free-Float |
31.71% | Yield 2024 |
4.16% | Yield 2025 | 10.5% |
| 1 day | -0.03% | ||
| 1 week | +4.59% | ||
| 1 month | -0.10% | ||
| 3 months | -5.69% | ||
| 6 months | -14.05% | ||
| Current year | -16.07% |
| 1 week | 36.1 |  | 38.92 |
| 1 month | 36.1 | | 40.36 |
| Current year | 34.7 | | 48.2 |
| 1 year | 34.7 | | 50.97 |
| 3 years | 23.4 | | 50.97 |
| 5 years | 17.98 | | 56.26 |
| 10 years | 11.8 | | 56.26 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jian Ma
DFI | Director of Finance/CFO | 48 | 2023-07-20 |
Hong Zhou
CTO | Chief Tech/Sci/R&D Officer | 56 | 2017-10-09 |
Jian Wang
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Lei Wang
CHM | Chairman | 55 | 2024-11-25 |
Hong Zhou
BRD | Director/Board Member | 56 | 2012-11-30 |
Jian Hua Xing
BRD | Director/Board Member | 55 | 2021-12-09 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.03% | +4.59% | -1.21% | -1.42% | 3.79B | |
| +0.21% | +3.65% | -6.09% | -1.40% | 13.96B | |
| +0.15% | +5.03% | -28.44% | -48.88% | 5.34B | |
| -1.12% | +7.35% | +5.65% | +10.86% | 5.16B | |
| +1.56% | +2.99% | +3.30% | -31.31% | 4.18B | |
| -0.33% | +0.68% | -0.85% | +7.53% | 3.66B | |
| +1.51% | +2.28% | -3.24% | +15.80% | 3.57B | |
| +0.90% | +2.07% | -14.25% | -22.36% | 2.46B | |
| -2.04% | +4.97% | -1.96% | +51.82% | 1.92B | |
| +0.38% | +4.90% | -39.52% | -12.25% | 1.76B | |
| Average | +0.12% | +2.26% | -8.66% | -3.16% | 4.58B | |
| Weighted average by Cap. | +0.16% | +2.68% | -7.03% | -5.55% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 7.31B 1.08B 940M 875M 804M 1.52B 103B 1.54B 10.32B 4.05B 51.41B 4.06B 3.97B 172B | 4.92B 728M 633M 589M 541M 1.02B 69.49B 1.04B 6.94B 2.72B 34.6B 2.73B 2.67B 116B |
| Net income | 2.23B 330M 287M 267M 245M 463M 31.51B 470M 3.15B 1.24B 15.68B 1.24B 1.21B 52.59B | 2.13B 315M 274M 255M 234M 443M 30.12B 449M 3.01B 1.18B 14.99B 1.18B 1.16B 50.27B |
| Net Debt | -3.91B -578M -503M -468M -430M -811M -55.2B -824M -5.52B -2.16B -27.48B -2.17B -2.12B -92.15B | -4.26B -630M -548M -510M -468M -884M -60.16B -898M -6.01B -2.36B -29.95B -2.37B -2.31B -100B |
Employees
3,890
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-31 | CN¥38.29 | -0.03% | 3,263,400 |
| 26-07-30 | CN¥38.30 | +0.52% | 4,169,400 |
| 26-07-29 | CN¥38.10 | +4.58% | 6,350,604 |
| 26-07-28 | CN¥36.43 | -1.49% | 3,610,100 |
| 26-07-27 | CN¥36.98 | +1.01% | 3,243,100 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600329 Stock
Select your edition
All financial news and data tailored to specific country editions
